Pfizer Infringed on Moderna Patent With COVID-19 Vaccine: Court

London’s High Court ruled that a second patent held by Moderna was invalid.

A nurse prepares to administer the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, England, on Dec. 8, 2020. Frank Augstein/Reuters

Pfizer and BioNTech’s COVID-19 vaccine infringed on a patent held by rival Moderna, the High Court in London, England, found in a decision released on July 2.

The Pfizer-BioNTech and Moderna COVID-19 vaccines both utilize messenger ribonucleic acid (mRNA) technology.